Efficacy and Safety of a Double Icodextrin Dose in Elderly Incident CAPD Patients on Incremental PD.
Status:
Completed
Trial end date:
2020-02-28
Target enrollment:
Participant gender:
Summary
The DIDo study is an open-label, randomised, multicentre study with 2 parallel groups in
incident CAPD patients aged of 65 at minimum :
- One group in which patients will receive 2 bags of icodextrin/day and 1 bag of glucose
- One group in which patients will receive 1 bag of icodextrin/day and 2 bags of glucose.